Transseptal Puncture for Left Atrial Ablation: Risk Factors for Cardiac Tamponade and a Proposed Causative Classification System
Overview
Physiology
Authors
Affiliations
Aims: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the associations of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our center from 2016 to 2020.
Methods And Results: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinized to adjudicate TSP culpability. Adjusted multivariate analysis examined predictors of TRCT. A total of 3239 consecutive TSPs were performed; cardiac tamponade occurred in 51 patients (incidence: 1.6%) and was adjudicated as TSP-related in 35 (incidence: 1.1%; 68.6% of all tamponades). Patients of above-median age [odds ratio (OR): 2.4 (1.19-4.2), p = .006] and those undergoing re-do procedures [OR: 1.95 (1.29-3.43, p = .042] were at higher risk of TRCT. Of the operator-dependent variables, choice of transseptal needle (Endrys vs. Brockenbrough, p > .1) or puncture sheath (Swartz vs. Mullins vs. Agilis vs. Vizigo vs. Cryosheath, all p > .1) did not predict TRCT. Adjusting for operator, equipment and demographics, failure to cross the septum first pass increased TRCT risk [OR: 4.42 (2.45-8.2), p = .001], whilst top quartile operator experience [OR: 0.4 (0.17-0.85), p = .002], transoesophageal echocardiogram [TOE prevalence: 26%, OR: 0.51 (0.11-0.94), p = .023], and use of the SafeSept transseptal guidewire [OR: 0.22 (0.08-0.62), p = .001] reduced TRCT risk. An increase in transseptal guidewire use over time (2016: 15.6%, 2020: 60.2%) correlated with an annual reduction in TRCT (R = 0.72, p < .001) and was associated with a relative risk reduction of 70%.
Conclusions: During left atrial ablation, the risk of TRCT was reduced by operator experience, TOE-guidance, and use of a transseptal guidewire, and was increased by patient age, re-do procedures, and failure to cross the septum first pass.
Bejinariu A, Augustin N, Spieker M, Auf der Heiden C, Angendohr S, Hockmann M J Clin Med. 2025; 14(1.
PMID: 39797186 PMC: 11722390. DOI: 10.3390/jcm14010103.
Tzeis S, Gerstenfeld E, Kalman J, Saad E, Sepehri Shamloo A, Andrade J J Arrhythm. 2024; 40(6):1217-1354.
PMID: 39669937 PMC: 11632303. DOI: 10.1002/joa3.13082.
Pacheco-Bouthillier A, Miguel-Gonzalez J, Gonzalez-Martinez A, Everding-Rodriguez A, Gomez-Delgadillo S, Chavez-Torres A Heart Rhythm O2. 2024; 5(11):788-795.
PMID: 39651438 PMC: 11624409. DOI: 10.1016/j.hroo.2024.09.005.
Obeidat O, Ismail M, Abughazaleh S, Al-Ani H, Tarawneh M, Alhuneafat L Med Int (Lond). 2024; 5(1):1.
PMID: 39563946 PMC: 11571048. DOI: 10.3892/mi.2024.200.
Jungen C, Rattka M, Bohnen J, Mavrakis E, Vlachopoulou D, Dorna S Int J Cardiol Heart Vasc. 2024; 55:101516.
PMID: 39403597 PMC: 11471536. DOI: 10.1016/j.ijcha.2024.101516.